StockData
Moleculin Biotech, Inc. logo

Moleculin Biotech, Inc. (MBRX) stock

MBRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 4/30
$6.83−0.31 (-4.34%)

Close on Nov 17, 2026Market cap $133.03MP/E –Yield –

Moleculin Biotech market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Moleculin Biotech's market cap was $57.51M on Nov 11, 2026, against $269.97M a year earlier. Over the last 5 years it ranged from $42.69M to $1.06B, with a median of $281.17M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$57.51M-56.1%
2025Dec 31, 2025$131.07M+28.4%
2024Dec 31, 2024$102.06M-80.1%
2023Dec 29, 2023$511.76M-15.7%
2022Dec 30, 2022$606.88M-42.9%
2021Dec 31, 2021$1.06B+8.0%
2020Dec 31, 2020$984.58M+17.7%
2019Dec 31, 2019$836.83M+49.8%
2018Dec 31, 2018$558.66M-27.9%
2017Dec 29, 2017$774.51M+40.9%
2016Dec 30, 2016$549.69M–

More Moleculin Biotech figures

See a number that looks wrong?